Arthneeti
AM

Anondita Medicare Ltd

Q2 FY27Personal Products

Anondita Medicare Q2 Results 2026 (FY27) statement: Revenue & Margins

Q2 FY27 results statement: what the company reported on revenue, margins and capex.

Anondita Medicare Ltd Q2 FY27 key numbers

Revenue
Revenue from operations for the quarter ended September 30, 2026: Rs. 7,354.17 lakhs.

As stated in Anondita Medicare Ltd's Q2 FY27 results statement · published 15 Nov 2026. Reported figures, not investment advice.

Based on Anondita Medicare Ltd's Q2 FY27 results statement. The company has not published an earnings-call transcript for this quarter, so figures here are what the results statement reports, not management guidance.

Price₹1,063
Market cap₹2.0K Cr
P/E60.5

The short version

Revenue from operations for the quarter ended September 30, 2026: Rs. 7,354.17 lakhs (Page 9). EBITDA for the quarter: ₹2,319.51 lakh, up from ₹1,666.81 lakh YoY (+39.12%).

From Anondita Medicare Ltd's Q2 FY27 earnings-call transcript · updated 15 Nov 2026.

How did Anondita Medicare's revenue grow in the September 2026 quarter?

- Revenue from operations for the quarter ended September 30, 2026: Rs. 7,354.17 lakhs (Page 9) - Revenue from operations for the quarter ended September 30, 2025: Rs. 5,409.70 lakhs (Page 9) - Year-on-year revenue growth: Rs. 7,354.17 lakhs vs. Rs. 5,409.70 lakhs, approx. 36% increase Summary: The presentation reports a 36% year-on-year increase in quarterly revenue from operations.

What happened to Anondita Medicare's margins in Q2 FY27?

EBITDA for the quarter: ₹2,319.51 lakh, up from ₹1,666.81 lakh YoY (+39.12%)

Locked: what Anondita Medicare Ltd said on margins

Also locked on this page: fundraising, order book

Free account, 30 seconds. No card needed.

What capex is Anondita Medicare planning?

The investor presentation in the PDF describes the following capital expenditure (capex) and expansion plans: - **Capital Work in Progress (CWIP):** - Standalone CWIP at Rs. 7,420.55 lakhs as of Sept 30, 2026 (page 3 & 8). - **Property, Plant & Equipment (PPE):** - Standalone PPE value Rs. 5,295.77 lakhs as of Sept 30, 2026, indicating ongoing asset addition (pages 3 & 8). - **Capex Spend:** - Significant purchase of/advances for PPE and intangible assets: Rs. 4,800.62 lakhs during the half-year ended Sept 30, 2026 (pages 5 & 10).

2 more points from Anondita Medicare Ltd's call on capex

Create a free account to keep reading this call

Top-ranked in Personal Products

Ranked on what management guided this quarter

Guidance-ranked
1Recode Studios
Rev 1Mar 3
2Emami
Rev 2Mar 3
3
Rev 2Mar 3
4
Rev 3Mar 3
5
Rev 3Mar 3
Sign up free to see 3 moreTakes 30 seconds · no cardSign up

Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.

Is Anondita Medicare raising money or cutting debt?

The standalone cash flow statement (Page 5) shows financing activities for the half year ended September…

Locked: what Anondita Medicare Ltd said on fundraising

Also locked on this page: margins, order book

Free account, 30 seconds. No card needed.

How big is Anondita Medicare's order book?

See what Anondita Medicare Ltd said on order book & pipeline — free account, 30 seconds.

More Q2 FY27 results in Personal Products

All Q2 FY27 results | Personal Products rankings

Continue your research

What Anondita Medicare's management said in earlier quarters

Others in Personal Products this season

  • Gillette India (Q2 FY27)

    Revenue from operations for the quarter ended 30th September 2026: ₹84,610 lakh (Page 3) . Key results statement takeaways from Gillette India Ltd's Q2 FY27 ear

  • Cupid (Q2 FY27)

    Q2 FY27 revenue from operations: ₹187.86 Crores, up 122.5% YoY (Q2 FY26: ₹84.45 Crores) [Page 14, 16] . Key investor presentation takeaways from Cupid Ltd's Q2

  • Honasa Consumer (Q2 FY27)

    Younger brands, excluding The Derma Co., are growing healthily at 40%+ year-on-year, with the overall portfolio showing strong momentum across online and…

  • Emami (Q2 FY27)

    Volume growth for domestic business recorded 43% in Q2 and 26% on a like-to-like basis, indicating strong demand. Key concall takeaways from Emami Ltd's Q2…

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →

Arthneeti Pro · Annual

Anondita Medicare Ltd and 15K+ more earnings calls,
for less than your morning chai

Every earnings call, ranking and concall Q&A across all four results seasons.

Secure Razorpay payment · instant access

Frequently Asked Questions

What were Anondita Medicare Ltd Q2 FY27 results?

Revenue from operations for the quarter ended September 30, 2026: Rs. 7,354.17 lakhs (Page 9). EBITDA for the quarter: ₹2,319.51 lakh, up from ₹1,666.81 lakh YoY (+39.12%).

What is Anondita Medicare Ltd share price analysis?

Anondita Medicare Ltd currently shows a neutral. The stock trades at a P/E of 60.5 with a market cap of ₹2,024 Cr. Investors should review the full earnings analysis for detailed insights.

Is Anondita Medicare Ltd planning capital expenditure?

The results statement in the PDF describes the following capital expenditure (capex) and expansion plans:.

Keep Anondita Medicare Ltd on your radar — track it to get its next earnings analysis in your feed.

This analysis is AI-generated based on publicly available earnings data and the company's results statement. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.